Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

Somatostatin analogues can suppress the secretion of some gastrointestinal hormones and growth factors involved in the growth regulation of gastrointestinal cancers and can inhibit the growth of experimental pancreatic tumours. Therefore, in a phase II study 34 patients with metastatic pancreatic (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Klijn, J. G., Hoff, A. M., Planting, A. S., Verweij, J., Kok, T., Lamberts, S. W., Portengen, H., Foekens, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971491/
https://www.ncbi.nlm.nih.gov/pubmed/1977468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971491/
https://www.ncbi.nlm.nih.gov/pubmed/1977468

Ejemplares similares